Fig. 3.
BMI, fasting plasma glucose, fasting serum insulin, and HOMA-IR before and after antiviral treatment in patients with genotype 1 HCV infection (A, n=15) and genotype 2 HCV infection (B, n=13). Data were obtained before and at 6 months after the end of antiviral treatment. Data are mean and SD values.
*p<0.05, †p<0.01.
BMI, body mass index; NS, not significant.